ecrin-mdr-crcClinical2008Colorectal CancerColorectal NeoplasmsColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2061270Greece11Second lineIrinotecanCapecitabine (Xeloda)OxaliplatinCapecitabineCetuximab (Erbitux)CetuximabMetastatic colorectal cancerECRIN MDRTerminatedfalseIrinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRCThis phase II study will evaluate which is the best way to administer cetuximab after recurrence in 1st line irinotecan+bevacizumab based treatment and to obtain results of the efficacy of the oxaliplatin+cetuximab combination as 2nd line treatment.2008-11-152061270NCT00755534